BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Lunaphore appoints Joseph Bernardo as new Chairman of the Board

  Lunaphore Technologies S.A. announces the appointment of Joseph E. Bernardo as its new Chairman of the Board of Directors, bringing the total to 5 members.

  September 1, 2019

   · 

  3 min read
• 

  Managing tumor heterogeneity: Proteona and AI Singapore partner to improve cell therapies and IO treatments through single cell analysis of tumors and CAR T cells

  Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology

  September 1, 2019

   · 

  4 min read
• Drug treatment for hydrocephalus, or water on the brain, is the target of IUPUI research team

  Pharmaceutical partner sought to license, develop as-needed treatment that reduces cerebrospinal fluid production

  September 1, 2019

   · 

  2 min read
• Drug Development

  BRILINTA Reduced the Risk of Cardiovascular Events in Patients With Coronary Artery Disease and Type 2 Diabetes in Phase III THEMIS Trial

  AstraZeneca announced detailed results from the positive Phase III THEMIS trial, which showed BRILINTA plus aspirin reduced the relative risk for the composite of cardiovascular death, heart attack, or stroke by 10% compared with aspirin alone, a statistically significant reduction.

  September 1, 2019

   · 

  7 min read
• Job Trends

  Magellan Health Provides Free Consultation Services and Referrals to Local Community Resources to Individuals Impacted by the Shooting in West Texas

  Magellan Health, Inc. announced that it will open a free 24-hour crisis line for all individuals impacted by the shooting that occurred outside Odessa, Texas.

  September 1, 2019

   · 

  1 min read
• Drug Development

  Detailed Results from Phase III DAPA-HF Trial Showed FARXIGA Significantly Reduced Both the Incidence of Cardiovascular Death and the Worsening of Heart Failure

  DAPA-HF is the first outcomes trial with an SGLT2 inhibitor in patients with heart failure with reduced ejection fraction, with and without type 2 diabetes

  September 1, 2019

   · 

  9 min read
• Mitsubishi Electric Develops World’s First Multi-Cell GaN-HEMT Bonded Directly to Diamond Substrate

  Will increase energy efficiency and reliability of microwave electronics in diverse fields

  September 1, 2019

   · 

  1 min read